Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Insipidus II: Pathophysiology

Diabetes Insipidus II: Pathophysiology

Normally, water balance is maintained through three interconnected mechanisms: the hypothalamic thirst center, the synthesis and release of antidiuretic hormone (ADH, or vasopressin), and the kidneys' responsiveness to this hormone. ADH is synthesized in the hypothalamus, released from the posterior pituitary, and acts on the distal nephron, allowing water reabsorption and concentrated urine production.Diabetes Insipidus and Its TypesIn diabetes insipidus (DI), this regulatory system is...

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

Disorders of the Urinary System

Disorders of the Urinary System

The urinary system is responsible for eliminating waste and excess fluids from the body. However, disorders of the urinary system can arise due to various reasons like infections, stress, age, congenital abnormalities, and lifestyle.
Urinary tract infections (UTIs) are one of the most common urinary system disorders. They are caused by bacteria that enter the urethra and can spread to the bladder resulting in cystitis. Pyelonephritis is the result of a UTI that has ascended to the level of the...

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

Diabetes Insipidus I: Introduction

Diabetes Insipidus I: Introduction

Definition Diabetes insipidus is a disorder marked by the production of large amounts of dilute urine because of impaired vasopressin production, release, or kidney response. The lack of effective vasopressin action limits water reabsorption in the renal collecting ducts, which leads to excessive urinary water loss and intense thirst.Clinical PresentationIndividuals with diabetes insipidus report persistent thirst and very high urine output. In severe cases, fluid intake can reach up to 20...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prognostic significance of Lin28A protein expression in papillary thyroid carcinoma.

Indian journal of pathology & microbiology·2025

Same author

An underrecognized association: immune checkpoint inhibitor-related aortitis, a case report with the review of the literature.

International cancer conference journal·2024

Same author

Effect of hyperparathyroidism on coagulation: a global assessment by modified rotation thromboelastogram (ROTEM)

Turkish journal of medical sciences·2021

Same author

Comparison Between the Maximum Standard Uptake Value and the Ratio of Lymph Node to Primary Tumor Attenuation in Head and Neck Cancers: A Prospective Study.

Current medical imaging·2021

Same author

Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study).

Lipids in health and disease·2020

Same author

Neopterin and biopterin levels and tryptophan degradation in patients with diabetes.

Scientific reports·2020

Search research articles

Related Experiment Video

Updated: Jul 15, 2026

Real-Time Void Spot Assay

Real-Time Void Spot Assay

Published on: February 10, 2023

Bladder dysfunction in type 2 diabetic patients.

Nur Kebapci¹, Aydin Yenilmez, Belgin Efe

¹Department of Endocrinology and Metabolism, Osmangazi University Medical Faculty, Eskişehir, Turkey. nkebapci@ogu.edu.tr

Neurourology and Urodynamics

|April 25, 2007

Summary

Diabetic cystopathy is common in type 2 diabetes, affecting bladder function. Factors like age, diabetes duration, and complications help predict bladder dysfunction in patients.

More Related Videos

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Published on: August 9, 2012

Related Experiment Videos

Last Updated: Jul 15, 2026

Real-Time Void Spot Assay

Real-Time Void Spot Assay

Published on: February 10, 2023

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Published on: August 9, 2012

Area of Science:

Urology
Endocrinology
Diabetology

Background:

Type 2 diabetes mellitus (T2DM) frequently leads to lower urinary tract symptoms (LUTS).
Urodynamic investigation is crucial for diagnosing bladder dysfunction (BD) in diabetic patients.
Understanding patient characteristics and chronic complications aids in reevaluating BD findings.

Purpose of the Study:

To reevaluate urodynamic findings of bladder dysfunction in type 2 diabetic patients.
To correlate patient characteristics and chronic diabetic complications with specific urodynamic findings.
To identify predictive factors for bladder dysfunction in type 2 diabetes.

Main Methods:

Urodynamic investigation was performed on 54 patients (27 male, 27 female) with LUTS.
Findings were classified into diabetic cystopathy (DC), detrusor overactivity, bladder outlet obstruction (BOO), or incontinence.
Evaluated parameters included HbA1C, retinopathy, nephropathy, and sensorimotor/autonomic neuropathies.

Main Results:

Bladder dysfunction (BD) was observed in 74.07% of men and 59.26% of women.
Diabetic cystopathy (DC) was the most frequent finding in both genders.
Predictive factors for BD included age, diabetes duration, HbA1C levels, QTc prolongation, retinopathy, and microalbuminuria.

Conclusions:

Diabetic cystopathy is the predominant urodynamic finding in type 2 diabetic patients.
Age, diabetes duration, metabolic control (HbA1C), and specific complications predict BD.
Early identification of DC, typically 8-9 years post-T2DM diagnosis, is vital for patient management.